Campo DC | Valor | Idioma |
dc.contributor.author | Coutinho, Elsimar Metzker | - |
dc.contributor.author | Melo, José F. | - |
dc.creator | Coutinho, Elsimar Metzker | - |
dc.creator | Melo, José F. | - |
dc.date.accessioned | 2013-03-06T17:27:53Z | - |
dc.date.available | 2013-03-06T17:27:53Z | - |
dc.date.issued | 1973 | - |
dc.identifier.issn | 0010-7824 | - |
dc.identifier.uri | http://www.repositorio.ufba.br/ri/handle/ri/8808 | - |
dc.description | Texto completo. Acesso restrito. p. 207–217 | pt_BR |
dc.description.abstract | Marked reduction of sperm count occurred in eight fertile men bearing subdermal
Silastic capsules containing testosterone who received 50 mg of either norgestrienone
or R 2323 twice weekly per OS. Four other men also bearing testosterone implants who
received an equivalent dose of norethindrone have not shown a similar drop in sperm
count. None of the patients who received either norgestrienone or R 2323 reported loss
of libido or potency. These results suggest one of these nor-steroids may be used for
a male contraceptive pill. | pt_BR |
dc.language.iso | en | pt_BR |
dc.publisher | Contraception | pt_BR |
dc.source | http://dx.doi.org/10.1016/0010-7824(73)90031-0 | pt_BR |
dc.title | Successful inhibition of spermatogenesis in man without loss of libido: A potential new approach to male contraception | pt_BR |
dc.title.alternative | Contraception | pt_BR |
dc.type | Artigo de Periódico | pt_BR |
dc.description.localpub | Salvador | pt_BR |
dc.identifier.number | v. 8, n. 3 | pt_BR |
Aparece nas coleções: | Artigo Publicado em Periódico (Faculdade de Medicina)
|